Innate Pharma Announces Conference Call and Webcast for Full Year 2020 Financial Results
March 16, 2021 02:00 ET
|
INNATE PHARMA
MARSEILLE, France, March 16, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will...
Innate Pharma organise une conférence téléphonique et un webcast pour ses résultats financiers 2020
March 16, 2021 02:00 ET
|
INNATE PHARMA
Marseille, 16 mars 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd'hui qu'elle organisera une...
Innate Pharma announces conference call and webcast for Full Year 2020 financial results
March 16, 2021 02:00 ET
|
INNATE PHARMA
Marseille, March 16, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold a...
Nouveau nombre d'actions et de droits de vote d'Innate Pharma au 1er février 2021
February 24, 2021 01:00 ET
|
INNATE PHARMA
Marseille, 24 févr. 2021 (GLOBE NEWSWIRE) -- Conformément aux articles L. 233-8 II du Code de Commerce et 223-16 du règlement général de l’Autorité des marchés financiers (l’« AMF »), Innate...
Number of shares and voting rights of Innate Pharma as of February 1, 2021
February 24, 2021 01:00 ET
|
INNATE PHARMA
Marseille, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des Marchés...
Number of shares and voting rights of Innate Pharma as of February 1, 2021
February 24, 2021 01:00 ET
|
INNATE PHARMA
MARSEILLE, France, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pursuant to the article L. 233-8 II of the French “Code de Commerce” and the article 223-16 of the French stock-market authorities (Autorité des...
Innate Pharma participera à la 10ème conférence annuelle SVB Leerink Global Healthcare Conference
February 17, 2021 01:00 ET
|
INNATE PHARMA
Marseille, 17 févr. 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce aujourd’hui que des membres de...
Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference
February 17, 2021 01:00 ET
|
INNATE PHARMA
Marseille, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announced today that members of its senior...
Innate Pharma to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
February 17, 2021 01:00 ET
|
INNATE PHARMA
MARSEILLE, France, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) announced today that members of its senior...
Innate Pharma Advances Lacutamab Clinical Development Program
February 09, 2021 01:00 ET
|
INNATE PHARMA
TELLOMAK trial progresses as cohort 2 of KIR3DL2-expressing mycosis fungoides patients advances to Stage 2 earlier than anticipated Company to initiate two new clinical trials to investigate...